60
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Investigation of proliferation and migration of tongue squamous cell carcinoma promoted by three chemokines, MIP-3α, MIP-1β, and IP-10

, , , , , & show all
Pages 4193-4203 | Published online: 29 Aug 2017

References

  • GanlyIPatelSShahJEarly stage squamous cell cancer of the oral tongue–clinicopathologic features affecting outcomeCancer2012118110111121717431
  • RothenbergSMEllisenLWThe molecular pathogenesis of head and neck squamous cell carcinomaJ Clin Invest201212261951195722833868
  • SahuNGrandisJRNew advances in molecular approaches to head and neck squamous cell carcinomaAnticancer Drugs201122765666421178766
  • GrivennikovSIGretenFRKarinMImmunity, inflammation, and cancerCell2010140688389920303878
  • MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
  • da SilvaJMSoaveDFMoreira Dos SantosTPSignificance of chemokine and chemokine receptors in head and neck squamous cell carcinoma: a critical reviewOral Oncol20165681627086481
  • BalkwillFCancer and the chemokine networkNat Rev Cancer20044754055015229479
  • CharoIFRansohoffRMThe many roles of chemokines and chemokine receptors in inflammationN Engl J Med2006354661062116467548
  • ChowMTLusterADChemokines in cancerCancer Immunol Res20142121125113125480554
  • OoYHShettySAdamsDHThe role of chemokines in the recruitment of lymphocytes to the liverDig Dis Basel Switz20102813144
  • BranaICallesALoRussoPMCarlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b studyTarget Oncol201510111112324928772
  • PientaKJMachielsJPSchrijversDPhase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancerInvest New Drugs201231376076822907596
  • SandhuSKPapadopoulosKFongPCA first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumorsCancer Chemother Pharmacol20137141041105023385782
  • MatsumuraSWangBKawashimaNRadiation-induced CXCL16 release by breast cancer cells attracts effector T cellsJ Immunol Baltim Md 19502008181530993107
  • MullerASonkolyEEulertCChemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapyInt J Cancer200611892147215716331601
  • RemmeleWStegnerHERecommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissuePathol198783138140 German
  • ChangKPKaoHKYenTCOverexpression of macrophage inflammatory protein-3α in oral cavity squamous cell carcinoma is associated with nodal metastasisOral Oncol201147210811321163685
  • RentoftMCoatesPJLoljungLWilmsTLaurellGNylanderKExpression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongueTumor Biol J Int Soc Oncodevelopmental Biol Med201435541914198
  • LusterADUnkelessJCRavetchJVGamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteinsNature198531560216726763925348
  • LiuJYLiFWangLPCTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinomaBr J Cancer2015113574775526284335
  • LoBKKYuMZlotyDCowanBShapiroJMcElweeKJCXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomasAm J Pathol201017652435244620228225
  • LoetscherMGerberBLoetscherPChemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytesJ Exp Med199618439639699064356
  • SallustoFLenigDMackayCRLanzavecchiaAFlexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytesJ Exp Med199818768758839500790
  • FuruyaMSuyamaTUsuiHUp-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosisHum Pathol200738111676168717707463
  • JonesDBenjaminRJShahsafaeiADorfmanDMThe chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemiaBlood200095262763210627472
  • MonteagudoCMartinJMJordaELlombart-BoschACXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factorsJ Clin Pathol200760659659916522748
  • BystryRSAluvihareVWelchKAKallikourdisMBetzAGB cells and professional APCs recruit regulatory T cells via CCL4Nat Immunol20012121126113211702067
  • PiriläEVäyrynenOSundquistEMacrophages modulate migration and invasion of human tongue squamous cell carcinomaPLoS One2015103e012089525811194
  • KaskasNMMoore-MedlinTMcClureGBEkshyyanOVanchiereJANathanCAOSerum biomarkers in head and neck squamous cell cancerJAMA Otolaryngol – Head Neck Surg2014140151124232368
  • OppenheimJJYangDBiragynAHowardOZPlotzPChemokine receptors on dendritic cells promote autoimmune reactionsArthritis Res Ther20024Suppl 3S183S188
  • AbikoYNishimuraMKusanoKExpression of MIP-3alpha/CCL20, a macrophage inflammatory protein in oral squamous cell carcinomaArch Oral Biol200348217117512642237
  • ManokawinchokeJOsathanonTPavasantPRegulation of osteoprotegerin expression by Notch signaling in human oral squamous cell carcinoma cell lineAsian Pac J Trop Biomed201668692697
  • SpragueAHKhalilRAInflammatory cytokines in vascular dysfunction and vascular diseaseBiochem Pharmacol200978653955219413999
  • ZhangHMYuanJCheungPGamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expressionMol Cell Biol200525146247625815988033
  • SidahmedAMELeónAJBosingerSECXCL10 contributes to p38-mediated apoptosis in primary T lymphocytes in vitroCytokine201259243344122652417
  • CampbellASAlboDKimseyTFWhiteSLWangTNMacrophage inflammatory protein-3alpha (mip-3alpha) promotes pancreatic cancer cell invasion by upregulation of matrix metalloproteinase-9 (MMP-9) productionJ Surg Res20031142250251
  • Zipin-RoitmanAMeshelTSagi-AssifOCXCL10 Promotes invasion-related properties in human colorectal carcinoma cellsCancer Res20076773396340517409450